Firms

Serrado Capital

New York, New York, United States

reports.adviserinfo.sec.govlinkedin.compharmiweb.com

New York healthcare investment firm led by Managing Partner Stewart Hen, active in therapeutics, life science tools, medical devices and public and private biotechnology investments. Its 2025 investment in Weave Bio and Hen’s 2026 strategic advisory role connect it to AI-driven regulatory science. Other disclosed financing participants include IO Biotech, Larimar Therapeutics and neurodegenerative disease developer Clene. Historic legal vehicles include Serrado Healthcare Fund LP and Serrado Opportunity Fund LLC; completed fund closing sizes have not been established. The available SEC CRD170304 report is a final exempt-reporting-adviser filing dated March20,2020, rather than evidence of current SEC registration. A public corporate website, authentic company logo and complete current staff directory were not identified; only the named managing partner is verified.

Founded
—
Type
Venture capital

Funds2

  • Serrado Healthcare Fund LP—
  • Serrado Opportunity Fund LLC—

Team

Operations and support

Stewart HenStewart HenManaging Partner

Co-investing

Character Capital
Innovation Endeavors
Magnetic Ventures
SymBiosis
TMV

Investments